Cargando…
Sustained relief of trigeminal neuropathic pain by a blood–brain barrier penetrable PPAR gamma agonist
The blood–brain barrier (BBB) and blood–nerve barrier ensure protection of the nervous system but pose a challenge for the treatment of pain since it restricts passage of many therapeutic drugs. Although it is unknown which blood–neural barrier is more relevant, or whether permeabilities are the sam...
Autores principales: | Zhang, Morgan, Hu, Min, Montera, Marena A, Westlund, Karin N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843736/ https://www.ncbi.nlm.nih.gov/pubmed/31588847 http://dx.doi.org/10.1177/1744806919884498 |
Ejemplares similares
-
Trigeminal neuropathic pain is alleviated by inhibition of Ca(v)3.3 T-type calcium channels in mice
por: Montera, Marena, et al.
Publicado: (2020) -
Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
por: Westlund, Karin N., et al.
Publicado: (2020) -
The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model
por: Vigil, Jacob M., et al.
Publicado: (2020) -
Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain
por: Kunamneni, Adinarayana, et al.
Publicado: (2023) -
Manganese-enhanced MRI reveals changes within brain anxiety and aversion circuitry in rats with chronic neuropathic pain- and anxiety-like behaviors
por: McIlwrath, Sabrina L., et al.
Publicado: (2020)